Yun‐Song Yang

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Yue Gong, Peng Ji, Yun‐Song Yang et al. · Cell Metabolism · 2020 · 491 citations · Full text

Medicine, Cancer Biology, Oncology +12

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Yi Xiao, Ding Ma, Yun‐Song Yang et al. · Cell Research · 2022 · 322 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +17

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Guan‐Tian Lang, Yi‐Zhou Jiang, Jinxiu Shi et al. · Nature Communications · 2020 · 84 citations · Full text

Medicine, Cancer Biology, Oncology +16

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 64 citations

Medicine, Oncology, Breast Oncology +8

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer

Jinli Wei, Yun‐Song Yang, Yi Xiao et al. · Journal for ImmunoTherapy of Cancer · 2021 · 55 citations · Full text

Life Sciences, Biochemistry, Oncology +17